Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only…
Browsing: WHO
A recent report from the World Health Organization (WHO) has raised concerns over the continued outbreaks of circulating vaccine-derived polioviruses…
University College Dublin (UCD) is leading MpoxVax AFRIVAC, a new €1.3 million international consortium that aims to rapidly deploy technology…
The Heads of the International Monetary Fund (IMF), the World Bank Group (WBG), and the World Health Organization (WHO) have agreed on broad principles for cooperation on pandemic preparedness.
The World Health Organisation (WHO) has approved Cecolin®, a Human Papillomavirus (HPV) vaccine for use in a single-dose schedule.
The World Health Organization (WHO) has granted Emergency Use Listing (EUL) status to the first mpox in vitro diagnostic (IVD), marking a critical step toward improving global access to mpox testing.
The World Health Organisation (WHO) has launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP) to tackle dengue and other Aedes-borne arboviruses.
The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to…
According to the World Health Organisation (WHO), unsafe medication practices and medication errors are a leading cause of injury and…
The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for the 2025 influenza season in the southern hemisphere. The announcement was made at an information session after a 4-day meeting on the Composition of Influenza Virus Vaccines. The meeting is held twice annually, once for the southern and once for the northern hemisphere.